Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...
Launches mentor-mentee plan for senior officersBy Nkiruka Nnorom The Nigeria Customs Service, NCS, has pledged to build its ...
Conexeu Completes 12-Month Preclinical P.R.O.O.F Study, Supporting Its Intended Move Into the $11 Billion Medical Aesthetics Market as a Platform¹ ...
Redwire Corporation (NYSE: RDW), a global leader in aerospace and defense technology solutions, announced today it has appointed pioneering industry leaders Paul Reichert, former Principal ...
Vyome receives Chinese patent covering formulation and therapeutic use claims relating to its proprietary besifloxacin topical gel programme for inflammatory acne: Cambridge, Mass ...
Teknimed operates a fully integrated business model spanning in-house formulation, product development, manufacturing and distribution The company serves around 280 OEMs and distributors in more than ...
VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
Ministers of Transport from the broader African Continent present Representatives of Foreign Governments from our African continent and abroad. Permanent Secretaries, Director Gen ...
Trade Brains on MSN
Cipla stock: What's next for India's largest pharma company by volume?
India, July 8 -- The Indian pharmaceuticals sector seems to be at a new stage of evolution wherein mere scale will not work anymore. With increased pressure on prices in generic medicines in the ...
Ministers of Transport from the broader African Continent present Representatives of Foreign Governments from our African continent and abroad. Permanent Secretaries, Director Gen ...
Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results